Tatischeff, 2023 - Google Patents
Extracellular vesicle-DNA: the next liquid biopsy biomarker for early cancer diagnosis?Tatischeff, 2023
View HTML- Document ID
- 8699262526614630672
- Author
- Tatischeff I
- Publication year
- Publication venue
- Cancers
External Links
Snippet
Simple Summary Each human cancer is a specific disease, but all cancers share the necessity of an early diagnosis for providing the optimal outcome for the patient. Liquid biopsy in blood, as a substitute to invasive tissue biopsies, brought the first important …
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
- C12N15/1034—Isolating an individual clone by screening libraries
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Martins et al. | Liquid biopsies: applications for cancer diagnosis and monitoring | |
| Wang et al. | Proteomic analysis of exosomes for discovery of protein biomarkers for prostate and bladder cancer | |
| Zeinali et al. | High-throughput label-free isolation of heterogeneous circulating tumor cells and CTC clusters from non-small-cell lung cancer patients | |
| Lousada-Fernandez et al. | Liquid biopsy in oral cancer | |
| Kulasinghe et al. | Capture of circulating tumour cell clusters using straight microfluidic chips | |
| Soung et al. | Exosomes in cancer diagnostics | |
| Fedorko et al. | Combination of MiR-378 and MiR-210 serum levels enables sensitive detection of renal cell carcinoma | |
| Kong et al. | Liquid biopsies in head and neck cancer: current state and future challenges | |
| Royo et al. | Comparative miRNA analysis of urine extracellular vesicles isolated through five different methods | |
| Monkman et al. | High-plex and high-throughput digital spatial profiling of non-small-cell lung cancer (NSCLC) | |
| Rappa et al. | Extracellular vesicles from thyroid carcinoma: The new frontier of liquid biopsy | |
| Moon et al. | Enrichment of exosome-like extracellular vesicles from plasma suitable for clinical vesicular miRNA biomarker research | |
| Chitoiu et al. | Multi-omics data integration in extracellular vesicle biology—utopia or future reality? | |
| Coccaro et al. | Molecular complexity of diffuse large B-cell lymphoma: can it be a roadmap for precision medicine? | |
| Tatischeff | Extracellular vesicle-DNA: the next liquid biopsy biomarker for early cancer diagnosis? | |
| Lourenço et al. | Urinary extracellular vesicles as potential biomarkers for urologic cancers: An overview of current methods and advances | |
| Kemény et al. | Melanoma cells can adopt the phenotype of stromal fibroblasts and macrophages by spontaneous cell fusion in vitro | |
| Aoki et al. | Prospects for comprehensive analyses of circulating tumor cells in tumor biology | |
| Lee et al. | Comparison of four commercial kits for isolation of urinary cell-free DNA and sample storage conditions | |
| Manganelli et al. | Expression of cellular and extracellular TERRA, TERC and TERT in hepatocellular carcinoma | |
| Bortoluzzi et al. | Small RNAs in circulating exosomes of cancer patients: a minireview | |
| Polatoglou et al. | Isolation and quantification of plasma cell-free DNA using different manual and automated methods | |
| Zabegina et al. | MiRNA let-7 from TPO (+) extracellular vesicles is a potential marker for a differential diagnosis of follicular thyroid nodules | |
| Rui et al. | Serum-exosome-derived miRNAs serve as promising biomarkers for HCC diagnosis | |
| Zanganeh et al. | The current landscape of glioblastoma biomarkers in body fluids |